GROUP ONE TRADING, L.P. - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 157 filers reported holding CARA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$81,354
-60.8%
48,425
-33.9%
0.00%
-100.0%
Q2 2023$207,436
-14.5%
73,299
+48.4%
0.00%0.0%
Q1 2023$242,500
-68.8%
49,389
-31.7%
0.00%
-50.0%
Q4 2022$776,416
+57.2%
72,292
+36.9%
0.00%
+100.0%
Q3 2022$494,000
-20.3%
52,824
-22.2%
0.00%0.0%
Q2 2022$620,000
+17.6%
67,915
+56.5%
0.00%0.0%
Q1 2022$527,000
+36.5%
43,404
+36.9%
0.00%
Q4 2021$386,000
+52.6%
31,714
+78.8%
0.00%
Q2 2021$253,000
-60.5%
17,741
-39.9%
0.00%
-100.0%
Q1 2021$640,000
-3.8%
29,501
-32.9%
0.00%0.0%
Q4 2020$665,000
+18.3%
43,964
-0.5%
0.00%
-50.0%
Q3 2020$562,000
-36.1%
44,189
-14.1%
0.00%
-50.0%
Q2 2020$880,000
+32.3%
51,434
+2.1%
0.00%
-20.0%
Q1 2020$665,000
-62.5%
50,363
-54.3%
0.01%
-58.3%
Q4 2019$1,775,000
+244.0%
110,205
+290.5%
0.01%
+200.0%
Q3 2019$516,000
-56.8%
28,224
-49.2%
0.00%
-63.6%
Q2 2019$1,195,000
+138.0%
55,570
+117.1%
0.01%
+83.3%
Q1 2019$502,000
+67.3%
25,595
+11.0%
0.01%
+100.0%
Q4 2018$300,000
+240.9%
23,049
+224.9%
0.00%
+200.0%
Q1 2018$88,000
+388.9%
7,094
+152.1%
0.00%
Q1 2016$18,000
-43.8%
2,814
+24.0%
0.00%
Q3 2015$32,000
-80.0%
2,270
-82.7%
0.00%
-100.0%
Q2 2015$160,00013,1450.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,204,449$10,8241.35%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,233,000$6,054,0301.14%
Chescapmanager LLC 1,160,392$5,6980.90%
DISCIPLINED GROWTH INVESTORS INC /MN 1,732,375$8,505,9610.22%
XTX Topco Ltd 107,610$528,3650.11%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 84,530$415,0420.08%
PINNACLE ASSOCIATES LTD 679,413$3,335,9180.07%
PDT Partners, LLC 102,010$500,8690.07%
FARALLON CAPITAL MANAGEMENT LLC 1,995,370$9,797,2670.05%
AXQ CAPITAL, LP 27,760$136,3020.05%
View complete list of CARA THERAPEUTICS INC shareholders